176 related articles for article (PubMed ID: 34307365)
1. PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway.
Li B; Jia R; Li W; Zhou Y; Guo D; Teng Q; Du S; Li M; Li W; Sun T; Ma D; Ji M; Ji C
Front Cell Dev Biol; 2021; 9():686695. PubMed ID: 34307365
[TBL] [Abstract][Full Text] [Related]
2. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
3. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.
Long X; Yu Y; Perlaky L; Man TK; Redell MS
Br J Haematol; 2015 Sep; 170(5):704-18. PubMed ID: 25974135
[TBL] [Abstract][Full Text] [Related]
4. Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.
O' Reilly E; Dhami SPS; Baev DV; Ortutay C; Halpin-McCormick A; Morrell R; Santocanale C; Samali A; Quinn J; O'Dwyer ME; Szegezdi E
Sci Rep; 2018 Oct; 8(1):15752. PubMed ID: 30361682
[TBL] [Abstract][Full Text] [Related]
5. Stromal cells promote chemoresistance of acute myeloid leukemia cells via activation of the IL-6/STAT3/OXPHOS axis.
Hou D; Wang B; You R; Wang X; Liu J; Zhan W; Chen P; Qin T; Zhang X; Huang H
Ann Transl Med; 2020 Nov; 8(21):1346. PubMed ID: 33313091
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
Pang Y; Zhao Y; Wang Y; Wang X; Wang R; Liu N; Li P; Ji M; Ye J; Sun T; Li J; Ma D; Lu F; Ji C
J Exp Clin Cancer Res; 2020 Aug; 39(1):158. PubMed ID: 32795319
[TBL] [Abstract][Full Text] [Related]
8. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Garrido SM; Appelbaum FR; Willman CL; Banker DE
Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy.
Chen T; Zhang G; Kong L; Xu S; Wang Y; Dong M
Life Sci; 2019 Mar; 221():187-195. PubMed ID: 30716336
[TBL] [Abstract][Full Text] [Related]
11. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
12. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
[TBL] [Abstract][Full Text] [Related]
13. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy.
You R; Hou D; Wang B; Liu J; Wang X; Xiao Q; Pan Z; Li D; Feng X; Kang L; Chen P; Huang H
J Leukoc Biol; 2022 Aug; 112(2):299-311. PubMed ID: 34927743
[TBL] [Abstract][Full Text] [Related]
15. PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
Pandolfi A; Stanley RF; Yu Y; Bartholdy B; Pendurti G; Gritsman K; Boultwood J; Chernoff J; Verma A; Steidl U
Blood; 2015 Aug; 126(9):1118-27. PubMed ID: 26170031
[TBL] [Abstract][Full Text] [Related]
16. Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report.
Long X; Gerbing RB; Alonzo TA; Redell MS
Oncotarget; 2017 Oct; 8(52):90037-90049. PubMed ID: 29163809
[TBL] [Abstract][Full Text] [Related]
17. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
[TBL] [Abstract][Full Text] [Related]
19. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
Macanas-Pirard P; Broekhuizen R; González A; Oyanadel C; Ernst D; García P; Montecinos VP; Court F; Ocqueteau M; Ramirez P; Nervi B
Oncotarget; 2017 Apr; 8(14):23073-23086. PubMed ID: 28160570
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
Hu K; Gu Y; Lou L; Liu L; Hu Y; Wang B; Luo Y; Shi J; Yu X; Huang H
J Hematol Oncol; 2015 Jan; 8():1. PubMed ID: 25622682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
